Tumour-promoting role of SOCS1 in colorectal cancer cells-Reference-Cited by-同舟云学术

Tumour-promoting role of SOCS1 in colorectal cancer cells

Published:2015-09-22 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Tobelaim William S.,Beaurivage Claudia,Champagne Audrey,Pomerleau Véronique,Simoneau Aline,Chababi Walid,Yeganeh Mehdi,Thibault Philippe,Klinck Roscoe,Carrier Julie C.,Ferbeyre Gerardo,Ilangumaran Subburaj,Saucier Caroline

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep14301.pdf

Reference50 articles.

1. Elliott, J., Hookham, M. B. & Johnston, J. A. The suppressors of cytokine signalling E3 ligases behave as tumour suppressors. Biochem Soc Trans 36, 464–8 (2008).

2. Zhang, J., Li, H., Yu, J. P., Wang, S. E. & Ren, X. B. Role of SOCS1 in tumor progression and therapeutic application. Int J Cancer 130, 1971–80 (2012).

3. Inagaki-Ohara, K., Kondo, T., Ito, M. & Yoshimura, A. SOCS, inflammation and cancer. Jak-Stat 2, e24053 (2013).

4. Linossi, E. M., Babon, J. J., Hilton, D. J. & Nicholson, S. E. Suppression of cytokine signaling: The SOCS perspective. Cytokine Growth Factor Rev 24, 241–8 (2013).

5. Gui, Y. et al. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma. Curr Pharm Des 20, 2922–33 (2014).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the pathological functions of SOCS in colorectal cancer: Current concepts and future perspectives;Pathology - Research and Practice;2024-10

2. Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization;Cell Communication and Signaling;2024-03-23

3. Interleukin-15 cytokine checkpoints in natural killer cell anti-tumor immunity;Current Opinion in Immunology;2023-10

4. Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells;Frontiers in Immunology;2023-08-31

5. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer;Carcinogenesis;2023-08-01